Phase 3 Type 2 Diabetes (T2DM) trials recruiting now

All Type 2 Diabetes (T2DM) trials, every phase

Phase 3 Type 2 Diabetes (T2DM) trials

• A Study of BGM0504 in Early T2DM With Obesity
  NCT07743983 · Phase: Phase 3 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 1 location
• A Study of BGM0504 in Participants With Type 2 Diabetes in Indonesia
  NCT07064486 · Phase: Phase 3 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 4 locations
• A Study to Evaluate the Effect of Obicetrapib/Ezetimibe 10 mg Fixed-Dose Combination or Obicetrapib 10 mg Daily on Top of Guideline-Recommended Lipid-Lowering Therapy in Participants With Type 2 Diabetes and/or Metabolic Syndrome
  NCT07219602 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · 20 locations
• Evaluate the Efficacy and Safety of GZR33 Injection in Patients With Type 2 Diabetes
  NCT07527078 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Vitamin D and Type 2 Diabetes - Treat-To-Target
  NCT07448974 · Phase: Phase 3 · Ages: 30 Years to 74 Years · Sex: All (male and female) · 1 location

Common questions

What does Phase 3 mean?

See how clinical trials work.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.